Niko McCarty is a PhD student in Bioengineering at the California Institute of Technology, where he uses quantitative, experimental methods to study gene regulation in bacteria. He holds a Masters in Systems and Synthetic Biology from Imperial College London.
Over the last few years, thousands of studies have employed CRISPR/Cas systems to edit, or transcriptionally regulate, individual genetic targets. But a new study has taken CRISPR to soaring heights. CRISPR/Cas is remarkably simple